Company
Andimed
-15.46%
Base:647
opening:647
High:636.1
low:544
change:2,630,005
Page Quote News Graphs Company Profile Recommendations
More articles on the subject:
Engaged in the development, manufacture and marketing of medical equipment for the treatment of skin rejuvenation, slimming and hair removal reports today that the revenue during All year 2021 Amounted to about $ 21.8 million, an increase of 52% compared to last year when the figure was $ 14.3 million. The total profit amounted to $ 5.1 million, an increase compared to the corresponding period then the figure was $ 0.3 million. After the reports, Endimed drops 13% in trading in Tel Aviv.
The company’s operating profit amounted to $ 3 million, compared to $ 0.5 million last year. The company’s gross profit amounted to about $ 10.1 million, an increase of 34% compared to last year when it stood at $ 7.5 million.
The company’s profit rate was 47% during the period, a decrease compared to last year when it amounted to 53% due to the increase in transportation prices due to the corona crisis. Andymed’s shareholders’ equity grew during the past year to about $ 13.8 million compared to about $ 8.5 million in 2020. The company’s cash balance stands at about $ 11.3 million compared to about $ 7.3 million last year.
During the year, the company made a number of strategic moves, including the appointment of Dr. Ziv Karni as Andimed’s technology consultant, as well as a collaboration with the L’Oréal Group. For the company, the L’Oreal Group wants to add the product sold to the L’Oreal Group to the cultivation protocol of its luxury product line. The company received an initial order from the L’Oreal Group for a product sold to the L’Oreal Group in the amount of hundreds of thousands of euros.
Comments on the article(0):
Your response has been received and will be published subject to system policies.
Thanks.
For a new response
Your response was not sent due to a communication problem, please try again.
Return to comment